[Occurrence of HLA-A, B, C antibodies in first, second, and third pregnancies (follow-up studies of 161 pregnancies].
In the course of their gravidity 161 women, among them 71 pregnant for the first time, 64 for the second time and 26 for the third time, were examined five times for the presence of cytotoxic HLA-A, B, C antibodies in NIH-LCT. This resulted in a total frequency of 23% of cytotoxic antibodies. Among those women pregnant for the first time there was an antibody rate of 18.3% (12.7% specifically), in those being in their second or third pregnancy the antibody rate amounted to 26%. In women with the second pregnancy the frequency of specific antibodies amounted to 17%, in those with the third pregnancy to 7.7%. HLA-antibodies were identified in the first gravida at the earliest between the 33rd and 40th week of pregnancy, in the second gravidas from the 12th to 16th or 33rd to 40th week of pregnancy and in the third gravidas from the 6th to 12th week. The results are discussed in comparison with HLA-mass screening of gravids carried out in the GDR in selected pregnant women and with other data taken from literature. They obtain a practical significance for performing a programme of HLA-antibody screening in a selected number of pregnant women with the aim of providing a possibility for gaining test sera from pregnant women for the purpose of improving the yield of test sera in comparison with the HLA-antibody screening test commonly used for pregnant women in the GDR.
Pischel
R
R
Bezirksblutspendezentrale Neuruppin, DDR.
D000961:Antilymphocyte Serum / Q000032:analysis*; D003601:Cytotoxicity Tests, Immunologic; D005260:Female; D015234:HLA-A Antigens / Q000276:immunology; D015235:HLA-B Antigens / Q000276:immunology; D015236:HLA-C Antigens / Q000276:immunology; D006801:Humans; D011247:Pregnancy / Q000276:immunology*; D013997:Time Factors
D000961:Antilymphocyte Serum; D015234:HLA-A Antigens; D015235:HLA-B Antigens; D015236:HLA-C Antigens
Vorkommen cytotoxischer HLA-A, B, C-Antikörper im Serum von Erst-, Zweit- und Drittgraviden (Verlaufsuntersuchungen bei 161 Graviden).